Review Article

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment

Table 3

Selected clinical trials using cytotoxic T lymphocytes (CTLs).

ReferencePatientsImmunologic responseClinical response

[97]
(GBM: 3, AA: 1)
PR: 3
[98]
(GBM: 6, AA: 1, Other: 5)
PR: 4
Others: [20, 97, 148154]